Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Change in Receivables: 2009-2025

Historic Change in Receivables for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $2.3 million.

  • Lifecore Biomedical's Change in Receivables rose 200.72% to $1.7 million in Q2 2025 from the same period last year, while for May 2025 it was $2.3 million, marking a year-over-year decrease of 30.68%. This contributed to the annual value of $2.3 million for FY2025, which is 30.68% down from last year.
  • Lifecore Biomedical's Change in Receivables amounted to $2.3 million in FY2025, which was down 30.68% from $3.3 million recorded in FY2024.
  • Over the past 5 years, Lifecore Biomedical's Change in Receivables peaked at $6.1 million during FY2022, and registered a low of -$19.9 million during FY2023.
  • In the last 3 years, Lifecore Biomedical's Change in Receivables had a median value of $2.3 million in 2025 and averaged -$4.8 million.
  • In the last 5 years, Lifecore Biomedical's Change in Receivables skyrocketed by 206.29% in 2022 and then tumbled by 424.88% in 2023.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Change in Receivables stood at -$5.8 million in 2021, then skyrocketed by 206.29% to $6.1 million in 2022, then slumped by 424.88% to -$19.9 million in 2023, then spiked by 116.36% to $3.3 million in 2024, then crashed by 30.68% to $2.3 million in 2025.